Magrath George
CIK: 0001999390•Chief Executive Officer
OfficerDirector
Primary company: Opus Genetics, Inc. (IRD)
Magrath George is a corporate insider (Chief Executive Officer) at Opus Genetics, Inc. (IRD) filing SEC Form 4 transactions. 18 transactions, totaling $256,580 in purchases and $0 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Sale | 9,475 | $2.95 | $28K | 1,731,869 | 7/23/2026 Filed: 7/23/2026 | Filing → | |
| Sale | 24,438 | $5.21 | $127K | 1,750,855 | 3/16/2026 Filed: 3/16/2026 | Filing → | |
| Award | 483,639 | - | - | 1,775,293 | 1/22/2026 Filed: 1/22/2026 | Filing → | |
| Tax Payment | 30,350 | $2.30 | $70K | 1,291,654 | 11/1/2025 Filed: 11/5/2025 | Filing → | |
| Tax Payment | 30,350 | $2.30 | $70K | 1,291,654 | 11/1/2025 Filed: 11/4/2025 | Filing → | |
| Award | 392,157 | $1.15 | $451K | 392,157 | 3/24/2025 Filed: 3/26/2025 | Filing → | |
| Award | 392,157 | - | - | 1,322,004 | 3/24/2025 Filed: 3/26/2025 | Filing → | |
| Award | 330,697 | $0.93 | $308K | 330,697 | 3/13/2025 Filed: 3/17/2025 | Filing → | |
| Award | 330,697 | - | - | 929,847 | 3/13/2025 Filed: 3/17/2025 | Filing → | |
| Purchase | 100,000 | $0.98 | $98K | 599,150 | 12/26/2024 Filed: 12/30/2024 | Filing → | |
| Award | 6,200 | - | - | 499,150 | 12/23/2024 Filed: 12/23/2024 | Filing → | |
| Purchase | 9,706 | $1.02 | $10K | 492,950 | 11/18/2024 Filed: 11/19/2024 | Filing → | |
| Purchase | 90,294 | $1.01 | $91K | 483,244 | 11/15/2024 Filed: 11/19/2024 | Filing → | |
| Tax Payment | 37,050 | $1.18 | $44K | 392,950 | 11/1/2024 Filed: 11/5/2024 | Filing → | |
Ocuphire Pharma, Inc. OCUP | Purchase | 5,000 | $1.75 | $9K | 430,000 | 5/17/2024 Filed: 5/21/2024 | Filing → |
Ocuphire Pharma, Inc. OCUP | Purchase | 25,000 | $1.96 | $49K | 425,000 | 3/18/2024 Filed: 3/20/2024 | Filing → |
Ocuphire Pharma, Inc. OCUP | Award | 600,000 | $0.00 | $0 | 600,000 | 11/1/2023 Filed: 11/3/2023 | Filing → |
Ocuphire Pharma, Inc. OCUP | Award | 400,000 | $0.00 | $0 | 400,000 | 11/1/2023 Filed: 11/3/2023 | Filing → |
Type
Sale
Shares
9,475
Price
$2.95
Value
$28K
Type
Sale
Shares
24,438
Price
$5.21
Value
$127K
Type
Award
Shares
483,639
Price
-
Value
-
Type
Tax Payment
Shares
30,350
Price
$2.30
Value
$70K
Type
Tax Payment
Shares
30,350
Price
$2.30
Value
$70K
Type
Award
Shares
392,157
Price
$1.15
Value
$451K
Type
Award
Shares
392,157
Price
-
Value
-
Type
Award
Shares
330,697
Price
$0.93
Value
$308K
Type
Award
Shares
330,697
Price
-
Value
-
Type
Purchase
Shares
100,000
Price
$0.98
Value
$98K
Type
Award
Shares
6,200
Price
-
Value
-
Type
Purchase
Shares
9,706
Price
$1.02
Value
$10K
Type
Purchase
Shares
90,294
Price
$1.01
Value
$91K
Type
Tax Payment
Shares
37,050
Price
$1.18
Value
$44K
Ocuphire Pharma, Inc.
OCUP
Type
Purchase
Shares
5,000
Price
$1.75
Value
$9K
Ocuphire Pharma, Inc.
OCUP
Type
Purchase
Shares
25,000
Price
$1.96
Value
$49K
Ocuphire Pharma, Inc.
OCUP
Type
Award
Shares
600,000
Price
$0.00
Value
$0
Ocuphire Pharma, Inc.
OCUP
Type
Award
Shares
400,000
Price
$0.00
Value
$0
AI Agent
Try asking...